Biosimilars 2020

Topics

• Novel immunotherapeutics to target Gram-negative bacterial infections
• Current status of antimicrobial resistance with industry-led insight into current strategies to tackle AMR
• Development of precision antibiotics: agents designed to meet the demands of stewardship
• Strategies to combat -lactamases
• The role of plasmids in the evolution of antimicrobial resistance

Who should Attend

• Chief Scientific Officers
• Research and Development Directors
• Heads of Global Antimicrobial Stewardship
• Chief Medical Officers
• Pharmaceutical Research & Development/ Drug Discovery Scientists